[Diabetes mellitus related common medical disorders: recent progress in diagnosis and
treatment topics: I. Pathophysiology, diagnosis and treatment: 9. Dyslipidemia]. - Abstract …

Non-insulin-dependent diabetes mellitus (NIDDM) is prone to early and rapid development
of atherosclerotic vascular disease. Coronary heart disease is the major cause of death in …

Use of the second-generation (atypical) antipsychotic agents has led to concerns about
possible adverse metabolic effects, including an increased risk of diabetes mellitus. The …

Hyper-und Dyslipidämie tragen zur kardiovaskulären Morbidität und Mortalität diabetischer
Patienten bei. Überzeugende Daten zeigen, dass durch die medikamentöse Therapie mit …

Hyper-und Dyslipidämie tragen zur kardiovaskulären Morbidität und Mortalität diabetischer
Patienten bei. Überzeugende Daten zeigen, dass durch die medikamentöse Therapie mit …

Dyslipidaemia is an important component of the metabolic syndrome observed in patients
with type 2 diabetes, and is characterized by moderate hypertriglyceridaemia and low levels …

OBJECTIVE: The goal of this 5-year naturalistic study of patients treated with clozapine was
to examine the incidence of treatment-emergent diabetes mellitus in relation to other factors …

During the last few years, concern has risen about a potential diabetes mellitus DM)-
inducing effect of some atypical antipsychotics, especially clozapine and olanzapine …

Louis Aronne, MD Xavier Pi-Sunyer, MD George Bray, MD pressants [TCAs], monoamine
oxidase inhibitors [MAOIs], selective serotonin reuptake inhibitors [SSRIs], mirtazapine …